A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
Clinical trial NCT06263231 · RECRUITING
Trial details
- NCT number
- NCT06263231
- Sponsor
- Intensity Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2027-12-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.